OraSure Technologies Target of Unusually High Options Trading (NASDAQ:OSUR)

OraSure Technologies, Inc. (NASDAQ:OSUR) saw some unusual options trading on Monday. Stock investors acquired 7,517 call options on the stock. This is an increase of approximately 1,165% compared to the average daily volume of 594 call options.

OraSure Technologies Trading Up 0.1%

OSUR stock traded up $0.01 during midday trading on Monday, hitting $4.46. The stock had a trading volume of 637,090 shares, compared to its average volume of 586,107. The firm has a market cap of $307.42 million, a P/E ratio of -4.29 and a beta of 1.02. The business has a fifty day moving average price of $3.63 and a two-hundred day moving average price of $3.09. OraSure Technologies has a 1-year low of $2.08 and a 1-year high of $4.58.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded OraSure Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, June 4th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, OraSure Technologies presently has an average rating of “Reduce” and an average price target of $3.00.

Insider Buying and Selling at OraSure Technologies

In related news, Director Steven Kyle Boyd acquired 25,000 shares of the stock in a transaction dated Thursday, May 14th. The stock was bought at an average cost of $2.99 per share, for a total transaction of $74,750.00. Following the completion of the transaction, the director directly owned 113,462 shares of the company’s stock, valued at $339,251.38. The trade was a 28.26% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 4.70% of the company’s stock.

Institutional Investors Weigh In On OraSure Technologies

Several large investors have recently added to or reduced their stakes in OSUR. Quadrature Capital Ltd bought a new stake in OraSure Technologies in the fourth quarter worth approximately $28,000. Prudential Financial Inc. acquired a new stake in shares of OraSure Technologies during the 2nd quarter worth approximately $31,000. Diversify Wealth Management LLC acquired a new stake in shares of OraSure Technologies during the 1st quarter worth approximately $36,000. Amundi bought a new stake in shares of OraSure Technologies in the 1st quarter valued at $47,000. Finally, SG Americas Securities LLC increased its stake in shares of OraSure Technologies by 77.7% in the 4th quarter. SG Americas Securities LLC now owns 19,748 shares of the medical instruments supplier’s stock valued at $48,000 after acquiring an additional 8,632 shares in the last quarter. Institutional investors and hedge funds own 93.50% of the company’s stock.

About OraSure Technologies

OraSure Technologies, Inc is a Bethlehem, Pennsylvania–based diagnostic and medical device company specializing in the development, manufacture and commercialization of point-of-care and self-testing products. Founded in 1988, OraSure has built a portfolio of oral fluid and other non-invasive specimen collection technologies that support the detection of infectious diseases, drugs of abuse, and health and wellness biomarkers.

The company’s flagship product, the OraQuick® rapid HIV test, was the first Food and Drug Administration–approved over-the-counter oral fluid test for the detection of HIV-1/2 antibodies.